MedTrace Logo

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

NCT06631794 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1170

Last updated 2024-10-08

No results posted yet for this study

Summary

This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.

This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.

Conditions

  • Teenagers

Interventions

BEHAVIORAL

A short talk about the importance of HPV vaccination

Investigator plan to set up a short talk to 3rd grade classes in addition to the usual sexual health training. The issue of HPV vaccination will be systematically addressed for 10 minutes to encourage catch-up vaccination. The usual training include different themes such us : definition of sexual health, anatomy, sexually transmitted infections contraception/condoms, menstrual cycles, voluntary interruption of pregnancy, consent, sexual abuse/violence/harassment, pornography, anti-discrimination.... A 45-minute talk will include 2 or 3 topics from the above list. A ten minutes of talk will be added to the usual training to explain the HPV vaccination (a topic not usually addressed in sexual health training), covering the following elements: definition of HPV infection

Sponsors & Collaborators

  • Agence Regionale de Sante d'Ile de France

    collaborator UNKNOWN

  • Ospharm coopérative

    collaborator UNKNOWN

  • French Interregional Group of Clinical Research and Innovation

    collaborator OTHER

  • Communauté professionnelle territoriale de santé

    collaborator UNKNOWN

  • Hopital Foch

    lead OTHER

Eligibility

Min Age
14 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-23
Primary Completion
2025-04-23
Completion
2025-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06631794 on ClinicalTrials.gov